Stock A000640 DONG-A SOCIO HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dong-A Socio Holdings Co., Ltd.

Equities

A000640

KR7000640003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
112,300 KRW -1.49% Intraday chart for Dong-A Socio Holdings Co., Ltd. -1.66% +11.19%
Mar. 20 Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 659,867 754,004 718,671 634,448 631,323 701,956 -
Enterprise Value (EV) 1 659,867 754,337 719,055 634,853 631,323 701,956 701,956
P/E ratio 33.4 x - 11.8 x 57.2 x - 10.6 x 9.13 x
Yield - 0.82% 1.3% 0.99% - 1.96% 1.96%
Capitalization / Revenue - 0.96 x 0.82 x 0.63 x 0.56 x 0.55 x 0.51 x
EV / Revenue - 0.96 x 0.82 x 0.63 x 0.56 x 0.55 x 0.51 x
EV / EBITDA - 7,257,507,822 x 5,942,466,170 x 5,842,701,002 x - - -
EV / FCF - - 11,776,734 x 32,785,736 x - - -
FCF Yield - - 0% 0% - - -
Price to Book - 0.84 x 0.74 x 0.65 x - 0.68 x 0.65 x
Nbr of stocks (in thousands) 6,138 6,155 6,249 6,251 6,251 6,251 -
Reference price 2 107,500 122,500 115,000 101,500 101,000 112,300 112,300
Announcement Date 4/23/20 2/17/21 2/23/22 2/16/23 2/1/24 - -
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - 783.3 880.5 1,013 1,132 1,274 1,380
EBITDA - 103.9 120.9 108.6 - - -
EBIT 1 - 50.61 61.6 37.83 77.03 90 103
Operating Margin - 6.46% 7% 3.73% 6.81% 7.06% 7.46%
Earnings before Tax (EBT) 1 - - 63 36.15 - 79 93
Net income 1 19.76 - 59.16 11.1 - 67 78
Net margin - - 6.72% 1.1% - 5.26% 5.65%
EPS 2 3,220 - 9,752 1,775 - 10,553 12,301
Free Cash Flow - - 61,025 19,351 - - -
FCF margin - - 6,930.68% 1,910.04% - - -
FCF Conversion (EBITDA) - - 50,459.38% 17,820.86% - - -
FCF Conversion (Net income) - - 103,151.94% 174,410.69% - - -
Dividend per Share 2 - 1,000 1,500 1,000 - 2,200 2,200
Announcement Date 4/23/20 2/17/21 2/23/22 2/16/23 2/1/24 - -
1KRW in Billions2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 223.3 261 269.4 261.1
EBITDA - - - -
EBIT 1 -2.001 14.23 22.43 3.195
Operating Margin -0.9% 5.45% 8.33% 1.22%
Earnings before Tax (EBT) - - - -
Net income 1 -6.128 9.256 26.25 -19.85
Net margin -2.74% 3.55% 9.74% -7.6%
EPS - - - -
Dividend per Share - - - -
Announcement Date 5/4/22 8/9/22 11/2/22 2/16/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - 332 384 404 - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - 3.198 x 3.173 x 3.724 x - - -
Free Cash Flow - - 61,025 19,351 - - -
ROE (net income / shareholders' equity) - 19.7% 6.32% 2.69% - 6.5% 7.3%
ROA (Net income/ Total Assets) - 11.2% 3.76% 0.65% - - -
Assets 1 - - 1,572 1,712 - - -
Book Value Per Share 2 - 146,297 156,424 157,087 - 165,462 173,202
Cash Flow per Share 2 - 13,922 21,245 12,138 - 23,614 22,830
Capex - 51.9 70.1 56.5 - - -
Capex / Sales - 6.63% 7.96% 5.58% - - -
Announcement Date 4/23/20 2/17/21 2/23/22 2/16/23 2/1/24 - -
1KRW in Billions2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
112,300 KRW
Average target price
155,000 KRW
Spread / Average Target
+38.02%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
DONG-A SOCIO HOLDINGS CO., LTD. Stock Dong-A Socio Holdings Co., Ltd.
+11.19% 510M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A000640 Stock
  4. Financials Dong-A Socio Holdings Co., Ltd.